Shanthi Sabarimurugan Selected Research

Biomarkers (Surrogate Marker)

8/2020	Diagnostic and Prognostic Significance of MiR-150 in Colorectal Cancer: A Systematic Review and Meta-Analysis.
1/2020	Prognostic Value of MicroRNAs in Stage II Colorectal Cancer Patients: A Systematic Review and Meta-Analysis.
1/2020	The Significance of miRNAs as a Prognostic Biomarker for Survival Outcome in T Cell - Acute Lymphoblastic Leukemia Patients: A Systematic Review and Meta-Analysis.
12/2019	Prognostic Significance of FOXC1 in Various Cancers: A Systematic Review and Meta-Analysis.
10/2019	Clinical Theragnostic Relationship between Drug-Resistance Specific miRNA Expressions, Chemotherapeutic Resistance, and Sensitivity in Breast Cancer: A Systematic Review and Meta-Analysis.
7/2019	Diagnostic and prognostic role of HE4 expression in multiple carcinomas: A protocol for systematic review and meta-analysis.
6/2019	miRNA Predictors of Pancreatic Cancer Chemotherapeutic Response: A Systematic Review and Meta-Analysis.
6/2019	Prognostic significance of blood inflammatory biomarkers NLR, PLR, and LMR in cancer-A protocol for systematic review and meta-analysis.
3/2019	Validation of miRNA prognostic significance in stage II colorectal cancer: A protocol for systematic review and meta-analysis of observational clinical studies.
3/2019	Prognostic miRNA classifiers in t cell acute lymphoblastic leukemia: Study protocol for a systematic review and meta-analysis of observational clinical studies.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Shanthi Sabarimurugan Research Topics

Disease

7	Neoplasms (Cancer) 01/2022 - 01/2019
3	Colorectal Neoplasms (Colorectal Cancer) 08/2020 - 03/2019
3	Carcinoma (Carcinomatosis) 01/2020 - 01/2019
3	Breast Neoplasms (Breast Cancer) 12/2019 - 01/2019
3	Pancreatic Neoplasms (Pancreatic Cancer) 06/2019 - 01/2018
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2020 - 03/2019
2	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 01/2020 - 03/2019
2	Head and Neck Neoplasms (Head and Neck Cancer) 11/2019 - 01/2019
1	Dengue (Dengue Fever) 02/2021
1	Virus Diseases (Viral Diseases) 02/2021
1	Prostatic Neoplasms (Prostate Cancer) 01/2021
1	COVID-19 10/2020
1	Neoplasm Metastasis (Metastasis) 12/2019
1	Ovarian Neoplasms (Ovarian Cancer) 07/2019
1	Ovarian Epithelial Carcinoma 07/2019
1	Nasopharyngeal Neoplasms (Cancer of the Nasopharynx) 01/2019
1	Nasopharyngeal Carcinoma 01/2019
1	Melanoma (Melanoma, Malignant) 12/2018

Drug/Important Bio-Agent (IBA)

13	MicroRNAs (MicroRNA)IBA 08/2020 - 01/2018
11	Biomarkers (Surrogate Marker)IBA 08/2020 - 01/2019
3	AntigensIBA 02/2021 - 07/2019
2	Proteins (Proteins, Gene)FDA Link 12/2019 - 07/2019
1	AntioxidantsIBA 01/2022
1	AntibodiesIBA 02/2021
1	CytokinesIBA 02/2021
1	Immunoglobulin G (IgG)IBA 02/2021
1	Immunoglobulin M (IgM)IBA 02/2021
1	Lutetium-177IBA 01/2021
1	LigandsIBA 01/2021
1	Prostate-Specific Antigen (Semenogelase)IBA 01/2021
1	VaccinesIBA 10/2020
1	Transcription Factors (Transcription Factor)IBA 12/2019
1	Tumor Biomarkers (Tumor Markers)IBA 07/2019
1	CarbohydratesIBA 07/2019
1	Fulvestrant (Faslodex)FDA Link 01/2019

Therapy/Procedure

4	Therapeutics 01/2022 - 01/2019
3	Drug Therapy (Chemotherapy) 01/2021 - 06/2019
1	Castration 01/2021
1	Radiotherapy 01/2020